ArticleOpen forum infectious diseases2019
Racial Differences in Clinical Phenotype and Hospitalization of Blastomycosis Patients.
Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 13 citations in OpenAlex.
- A comparative analysis estimating aspergillosis and histoplasmosis encounters among inpatients in the United States using multi-regional electronic health record and National Discharge Data, 2014-2020.AJE advances : research in epidemiology · 2026Article
- Updating the Epidemiology of Blastomycosis and Histoplasmosis in the United States, Using National Electronic Health Record Data, 2013-2023.The Journal of infectious diseases · 2025Article
- Practical Guidance for Clinical Microbiology Laboratories: Antibody and antigen detection methods for dimorphic fungal infections.Clinical microbiology reviews · 2025Review
- Siblings in the ICU: Keeping Endemic Mycoses on the Differential.Case reports in pediatrics · 2025Article
- Clinical Presentation of Blastomycosis is Associated With Infecting Species, Not Host Genotype.Clinical medicine & research · 2024Article
- Blastomycosis of the Central Nervous System.Journal of radiology case reports · 2023Article
- Race and ethnicity: Risk factors for fungal infections?PLoS pathogens · 2023Review
- Demographic and Socioeconomic Factors Associated with Fungal Infection Risk, United States, 2019.Emerging infectious diseases · 2022Review
- Endemic and Other Dimorphic Mycoses in The Americas.Journal of fungi (Basel, Switzerland) · 2021Review
- Spontaneous resolution of blastomycosis symptoms caused byMedical mycology case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDimorphic fungal infections, such as blastomycosis, cause significant morbidity and mortality. Historically, blastomycosis studies have focused on non-Hispanic whites, which limits our understanding of the clinical presentation and outcomes for patients of other races and ethnicities. We evaluated whether clinical presentation and disease severity varied across racial and ethnic groups.
methodsBlastomycosis patients were identified from Marshfield Clinic Health System and data were abstracted from electronic medical records.
resultsIn total, 477 patients were included. Age differences were observed across race and ethnicity categories (
conclusionsHispanic whites, AIAN, and Asian blastomycosis patients were younger and healthier but more frequently hospitalized. Patients in these racial and ethnic groups may need more aggressive treatment and closer therapeutic monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.